India to Myanmar: Empagliflozin Export Trade Route
India has recorded 11 verified shipments of Empagliflozin exported to Myanmar, representing a combined trade value of $208.4K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $18.9K USD. The leading Indian exporter is DELTA BIOPHARMA PRIVATE LIMITED, which accounts for 80% of total export value with 9 shipments worth $167.1K USD. On the buying side, PINNACLE HOUSE CO., LTD is the largest importer in Myanmar with $135.3K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Myanmar Empagliflozin corridor is one of India's established pharmaceutical export routes, with 11 shipments documented worth a combined $208.4K USD. The route is dominated by DELTA BIOPHARMA PRIVATE LIMITED, which alone accounts for roughly 80% of all export value, reflecting the consolidated nature of India's empagliflozin manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $18.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with empagliflozin's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 15.1%, placing it at rank #9 among India's top empagliflozin export destinations globally.
On the import side, key buyers of Indian empagliflozin in Myanmar include PINNACLE HOUSE CO., LTD, PINNACLE HOUSE CO LTD, PINNACLE HOUSE CO, LTD and 2 others. PINNACLE HOUSE CO., LTD is the single largest importer with 4 shipments valued at $135.3K USD.
Route Characteristics
- Average transit21 days
- Peak seasonQ2
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#9
- Annual growth+15.1%
- Demand growth+13.2%
- Regulatory ease74/100
Top 10 Indian Empagliflozin Exporters to Myanmar
Showing top 10 of 2 Indian suppliers exporting Empagliflozin to Myanmar, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DELTA BIOPHARMA PRIVATE LIMITED Avg $18.6K per shipment | 9 | $167.1K | 80.2% |
| 2 | DELTA BIOPHARMA PVT LTD Avg $20.7K per shipment | 2 | $41.3K | 19.8% |
This table shows the top 10 of 2 Indian companies exporting empagliflozin to Myanmar, ranked by total trade value. The listed exporters are: DELTA BIOPHARMA PRIVATE LIMITED, DELTA BIOPHARMA PVT LTD. DELTA BIOPHARMA PRIVATE LIMITED is the dominant supplier with 9 shipments worth $167.1K USD, giving it a 80% market share.
Top 10 Empagliflozin Importers in Myanmar
Showing top 10 of 5 known buyers in Myanmar receiving Empagliflozin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian empagliflozin in Myanmar include PINNACLE HOUSE CO., LTD, PINNACLE HOUSE CO LTD, PINNACLE HOUSE CO, LTD, PINNACLE HOUSE CO. LTD, PINNACLE HOUSE CO LIMITED. The largest importer is PINNACLE HOUSE CO., LTD, accounting for $135.3K USD across 4 shipments — representing 65% of all empagliflozin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PINNACLE HOUSE CO., LTD | 4 | $135.3K | 65.0% |
| 2 | PINNACLE HOUSE CO LTD | 2 | $41.3K | 19.8% |
| 3 | PINNACLE HOUSE CO, LTD | 1 | $13.4K | 6.4% |
| 4 | PINNACLE HOUSE CO. LTD | 1 | $13.2K | 6.3% |
| 5 | PINNACLE HOUSE CO LIMITED | 3 | $5.1K | 2.5% |
Top 10 Empagliflozin Formulations Imported by Myanmar
Showing top 10 of 9 product formulations shipped on the India to Myanmar Empagliflozin route, ranked by trade value
Myanmar imports a wide range of empagliflozin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — "Emflozin 25mg (Empagliflozin Tablet 25mg) MYR Regn No: 2610EA00358 BATCH No: DF0044 Each pack contains=30Tablets MFG D — accounts for $82.3K USD across 1 shipments. A total of 9 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | "Emflozin 25mg (Empagliflozin Tablet 25mg) MYR Regn No: 2610EA00358 BATCH No: DF0044 Each pack contains=30Tablets MFG D | 1 | $82.3K | 39.5% |
| 2 | "Emflozin 10mg (Empagliflozin Tablet 10mg) PACK SIZE: 3X10'S MYR Regn No: 2610EA00359 BATCH No.DF0045 MFG Dt: 06/2024; | 1 | $39.1K | 18.8% |
| 3 | "EMFLOZIN 25[EMPAGLIFLOZIN TABLETS 25 MG | 1 | $27.5K | 13.2% |
| 4 | EMFLOZIN 25 EMPAGLIFLOZIN TABLETS 25 MG PACK SIZE 3X10S MYANMAR REG NO 2610EA00358 BATCH NO CG0016 | 1 | $13.8K | 6.6% |
| 5 | EMFLOZIN 10 (EMPAGLIFLOZIN TABLETS 10 MG | 1 | $13.4K | 6.4% |
| 6 | EMFLOZIN 10 (EMPAGLIFLOZIN TABLETS 10 MG ) MYANMAR REG NO. 2610EA00359 PACK SIZE. 3 X 10 S MFG DT. JAN 2025, EXP DT. DEC | 1 | $13.2K | 6.3% |
| 7 | EMFLOZIN 10 (EMPAGLIFLOZIN TABLETS 10 MG) Myanmar Reg No: 2610EA00359 Pack Size: 3 X 10'S MFG Dt: JAN 2025; EXP Dt: DEC | 1 | $13.2K | 6.3% |
| 8 | EMFLOZIN 10 (EMPAGLIFLOZIN TABLETS 10 MG) MYANMAR REG NO 2610EA00359 PACK SIZE 3 X 10S MFG DT SEP 2023 EXP DT ANOS | 3 | $5.1K | 2.5% |
| 9 | "Emflozin 10mg (Empagliflozin Tablet 10mg) MYR Regn No: 2610EA00359 PACK SIZE:3X10'S MFG Dt: 06/2024; EXP Dt: 05/2027 | 1 | $746 | 0.4% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 72%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 3 shipments. Transit time averages 21 days by sea.
Market Dynamics
India's empagliflozin exports to Myanmar are driven primarily by a handful of large-scale manufacturers. DELTA BIOPHARMA PRIVATE LIMITED with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — DELTA BIOPHARMA PRIVATE LIMITED, DELTA BIOPHARMA PVT LTD — together account for 100% of total trade value on this route. The average shipment value of $18.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as "emflozin 10mg (empagliflozin tablet 10mg) pack size: 3x10's myr regn no: 2610ea00359 batch no.df0045 mfg dt: 06/2024; and "emflozin 25[empagliflozin tablets 25 mg, suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, PINNACLE HOUSE CO., LTD is the largest importer with 4 shipments worth $135.3K USD — representing 65% of all empagliflozin imports from India on this route.
Route Statistics
- Trade Volume
- $208.4K
- Avg. Shipment
- $18.9K
- Suppliers
- 2
- Buyers
- 5
- Transit (Sea)
- ~21 days
- Annual Growth
- +15.1%
Related Analysis
Other Empagliflozin Routes
Unlock the Full India to Myanmar Empagliflozin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 11 shipments on this route.
Frequently Asked Questions — India to Myanmar Empagliflozin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Empagliflozin to Myanmar?
The leading Indian exporters of Empagliflozin to Myanmar are DELTA BIOPHARMA PRIVATE LIMITED, DELTA BIOPHARMA PVT LTD. DELTA BIOPHARMA PRIVATE LIMITED holds the largest market share at approximately 80% of total trade value on this route.
Q What is the total value of Empagliflozin exports from India to Myanmar?
India exports Empagliflozin to Myanmar worth approximately $208.4K USD across 11 recorded shipments. The average value per shipment is $18.9K USD.
Q Which ports does India use to ship Empagliflozin to Myanmar?
The most active port of origin is SAHAR AIR with 3 shipments. Indian exporters primarily use sea freight for this route, with 72% of shipments going by sea and 21% by air.
Q How long does shipping take from India to Myanmar for Empagliflozin?
The average transit time for Empagliflozin shipments from India to Myanmar is approximately 21 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Myanmar Empagliflozin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 15.1% with demand growth tracking at 13.2%. The route is ranked #9 among India's top Empagliflozin export destinations globally.
Q How many suppliers are active on the India to Myanmar Empagliflozin route?
There are currently 2 active Indian suppliers exporting Empagliflozin to Myanmar. The market is moderately concentrated with DELTA BIOPHARMA PRIVATE LIMITED accounting for 80% of total shipment value.
Q Who are the main importers of Empagliflozin from India in Myanmar?
The leading importers of Indian Empagliflozin in Myanmar include PINNACLE HOUSE CO., LTD, PINNACLE HOUSE CO LTD, PINNACLE HOUSE CO, LTD, PINNACLE HOUSE CO. LTD, PINNACLE HOUSE CO LIMITED. PINNACLE HOUSE CO., LTD is the largest buyer with 4 shipments worth $135.3K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Myanmar export trade corridor identified from Indian Customs (DGFT) records for Empagliflozin.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 5 importers in Myanmar matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 11 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
11 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists